Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- USD | -.--% | -.--% | -.--% |
2018 | Transcript : Aralez Pharmaceuticals Inc., Q1 2018 Earnings Call, May 08, 2018 | |
2018 | Transcript : Aralez Pharmaceuticals Inc., Q4 2017 Earnings Call, Mar 13, 2018 |
Umsatz 2016 | 54.27 Mio. 49.18 Mio. | Umsatz 2017 | 106 Mio. 96.01 Mio. | Marktwert | 94.98 Mio. 86.07 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2016 | -103 Mio. -93.34 Mio. | Nettoergebnis 2017 | -125 Mio. -113 Mio. | EV / Sales 2016 | 9.18 x |
Nettoschuld 2016 | 209 Mio. 190 Mio. | Nettoschuld 2017 | 246 Mio. 223 Mio. | EV / Sales 2017 | 3.22 x |
KGV 2016 |
-2.53
x | KGV 2017 |
-0.75
x | Beschäftigte | - |
Rendite 2016 * |
-
| Rendite 2017 |
-
| Streubesitz | 100% |
% 1. Jan. | Kap. | |
---|---|---|
-.--% | 0 | |
+32.92% | 698 Mrd. | |
+26.51% | 568 Mrd. | |
-4.62% | 358 Mrd. | |
+19.43% | 328 Mrd. | |
+3.46% | 283 Mrd. | |
+16.34% | 238 Mrd. | |
+6.68% | 203 Mrd. | |
-9.08% | 198 Mrd. | |
+8.83% | 165 Mrd. |